Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)

NCT04397692 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

Corona Virus Infection
COVID-19
SARS-CoV 2
Nitric Oxide
Respiratory Disease
Pneumonia, Viral
Inhaled Nitric Oxide

Interventions

DEVICE: Nitric Oxide delivered via LungFit™ system

Sponsor

Beyond Air Inc.